Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-05-18
Original SEC Filing: Click here

---

Webplus: SKBI/20100518/8-K_1/2_EX-99.1/000.htm SEC Original: v185715_ex99-1.htm
NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 — – Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) (“Skystar” or the “Company”), First Quarter 2009 Highligh ts

---

---

Webplus: SKBI/20100518/8-K_1/1/000.htm SEC Original: v185715_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): May 18, 2010 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188[Missing Graphic Reference] (Issuer Telephone Number) N/A (Former

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-05-18CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE